Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy with an annual incidence
of~ 1 case per million population. Differentiating between ACC and benign adrenocortical …

Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. The current
treatment standards include complete surgical resection for localized resectable disease …

Introduction: Adrenocortical carcinoma (ACC) is a rare tumor, often discovered at an
advanced stage and associated with poor prognosis. Treatment is guided by staging …

Background Although advocated by some, minimally invasive adrenalectomy (MIA) for
adrenocortical carcinoma (ACC) is controversial. Moreover, the oncologic implications for …

Adrenocortical carcinoma (ACC) is a rare but highly aggressive malignancy. Nearly half of
ACC tumours overproduce and secrete adrenal steroids. Excess cortisol secretion, in …

Adrenocortical carcinoma (ACC) is a rare malignancy that is associated with a dismal
prognosis. Pan-genomic studies have demonstrated the involvement of ATRX and ZNRF3 …

Background Adrenocortical carcinoma (ACC) is a rare but aggressive malignancy, and
many prognostic factors that influence survival remain undefined. Individually, the GRAS …

Abstract Background At presentation, 21% to 49% of patients with adrenocortical cancer
have metastases. Standard chemotherapy has a 23% response rate. We assessed whether …

Background Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with a
poor prognosis. Given the limited treatment options, prognostic assessment of ACC is …

This study aims to construct a robust prognostic model for adult adrenocortical carcinoma
(ACC) by large‐scale multiomics analysis and real‐world data. The RPPA data, gene …